NCT02921048

Brief Summary

This observational study recruits healthy individuals who have been routinely taking high amount (at least 3 g/wk) of dietary eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), and those who don't, and examines the efficacy of dietary EPA and DHA in ameliorating the cardiopulmonary effects of exposure to ambient air pollution.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
62

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2016

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 15, 2016

Completed
13 days until next milestone

First Submitted

Initial submission to the registry

September 28, 2016

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 30, 2016

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 15, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 15, 2019

Completed
Last Updated

May 10, 2022

Status Verified

May 1, 2022

Enrollment Period

3.2 years

First QC Date

September 28, 2016

Last Update Submit

May 8, 2022

Conditions

Keywords

Eicosapentaenoic AcidDocosahexaenoic AcidAmbient Air Pollution

Outcome Measures

Primary Outcomes (1)

  • heart rate variability

    Sep. 2016 to Sep 2019

Secondary Outcomes (4)

  • endothelial cell function

    Sep. 2016 to Sep 2019

  • diameters of retinal arteries and veins

    Sep. 2016 to Sep 2019

  • pulmonary function indices

    Sep. 2016 to Sep 2019

  • blood biomarkers

    Sep. 2016 to Sep 2019

Study Arms (2)

omega-3

individuals voluntarily taking at least 3 g/wk of EPA and DHA from dietary sources including fish oil supplements and ocean fish/shellfish consumption for a period of at least 6 months prior to enrollment in the study

Dietary Supplement: omega-3 fatty acids

control

individuals who have consumed no more than 1 serving size (4-6 oz)/month of ocean fish/shellfish, or no more than 1 pill/month of fish oil supplement during the 6 month period preceding enrollment

Interventions

omega-3 fatty acidsDIETARY_SUPPLEMENT
omega-3

Eligibility Criteria

Age25 Years - 55 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

Healthy 35-55 year-old male and female subjects

You may qualify if:

  • Aged 25-55 years old healthy male and female (19≤BMI≤30).
  • Normal resting ECG. No history of heart arrhythmia.
  • Oxygen saturation greater than 96% at the time of physical exam.
  • Taking at least 3 grams of EPA and DHA from dietary sources including fish oil supplements and ocean fish/shellfish for a 6 months or longer period of time preceding enrollment in the study; or taking no more than 1 serving size (4-6 oz)/month of ocean fish/shellfish, or no more than 1 pill/month of fish oil supplement during the previous 6 months or longer period of time.

You may not qualify if:

  • Individuals with a history of acute or chronic cardiovascular disease, such as myocardial infarction.
  • Individuals with a history of chronic respiratory disease, such as COPD and asthma.
  • Individuals with a history of cancer (possible exception for history of non-melanoma skin cancer).
  • Uncontrolled hypertension (≥150 systolic, ≥90 diastolic).
  • Individuals who are diabetic (previously diagnosed or with hemoglobin A1c level \>6.4%).
  • Individuals who are currently smoking (including vaping, or using hookah or e cigarettes) or have a smoking history within 1 year of study (defined as more than 1 pk/yr in the past year) or have a greater than/equal to a 5 pack year smoking history.
  • Individuals living with a smoker who smokes inside the house.
  • Individuals who are regularly exposed to high levels of vapors, dust, gases, or fumes.
  • Individuals who do not understand or speak English.
  • Individuals who are taking b-blocker medications.
  • Individuals who are taking statins.
  • Individuals that are unwilling or unable to maintain their current dietary pattern for the whole study.
  • Individuals with bleeding or clotting disorders.
  • Individuals who have active allergies.
  • Individuals who have an allergy to latex, or skin allergy to tape or electrodes.
  • +4 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

EPA Human Studies Facility

Chapel Hill, North Carolina, 27514, United States

Location

Related Publications (3)

  • Chen H, Zhang S, Shen W, Salazar C, Schneider A, Wyatt LH, Rappold AG, Diaz-Sanchez D, Devlin RB, Samet JM, Tong H. Omega-3 fatty acids attenuate cardiovascular effects of short-term exposure to ambient air pollution. Part Fibre Toxicol. 2022 Feb 9;19(1):12. doi: 10.1186/s12989-022-00451-4.

  • Chen H, Zhang S, Shen W, Salazar C, Schneider A, Wyatt L, Rappold AG, Diaz-Sanchez D, Devlin RB, Samet JM, Tong H. The influence of dietary intake of omega-3 polyunsaturated fatty acids on the association between short-term exposure to ambient nitrogen dioxide and respiratory and cardiovascular outcomes among healthy adults. Environ Health. 2021 Dec 7;20(1):123. doi: 10.1186/s12940-021-00809-9.

  • Tong H, Zhang S, Shen W, Chen H, Salazar C, Schneider A, Rappold AG, Diaz-Sanchez D, Devlin RB, Samet JM. Lung Function and Short-Term Ambient Air Pollution Exposure: Differential Impacts of Omega-3 and Omega-6 Fatty Acids. Ann Am Thorac Soc. 2022 Apr;19(4):583-593. doi: 10.1513/AnnalsATS.202107-767OC.

MeSH Terms

Interventions

Fatty Acids, Omega-3

Intervention Hierarchy (Ancestors)

Dietary Fats, UnsaturatedDietary FatsFatsLipidsFatty Acids, UnsaturatedFatty AcidsFish OilsOils

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
FED
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research biologist

Study Record Dates

First Submitted

September 28, 2016

First Posted

September 30, 2016

Study Start

September 15, 2016

Primary Completion

November 15, 2019

Study Completion

November 15, 2019

Last Updated

May 10, 2022

Record last verified: 2022-05

Locations